Page last updated: 2024-09-03

l 158809 and 2-(2-(5-bromo-1h-indol-3-yl)ethyl)-3-(1-methylethoxyphenyl)-4-(3h)-quinazolinone

l 158809 has been researched along with 2-(2-(5-bromo-1h-indol-3-yl)ethyl)-3-(1-methylethoxyphenyl)-4-(3h)-quinazolinone in 1 studies

Compound Research Comparison

Studies
(l 158809)
Trials
(l 158809)
Recent Studies (post-2010)
(l 158809)
Studies
(2-(2-(5-bromo-1h-indol-3-yl)ethyl)-3-(1-methylethoxyphenyl)-4-(3h)-quinazolinone)
Trials
(2-(2-(5-bromo-1h-indol-3-yl)ethyl)-3-(1-methylethoxyphenyl)-4-(3h)-quinazolinone)
Recent Studies (post-2010) (2-(2-(5-bromo-1h-indol-3-yl)ethyl)-3-(1-methylethoxyphenyl)-4-(3h)-quinazolinone)
1370725010

Protein Interaction Comparison

ProteinTaxonomyl 158809 (IC50)2-(2-(5-bromo-1h-indol-3-yl)ethyl)-3-(1-methylethoxyphenyl)-4-(3h)-quinazolinone (IC50)
Gastrin/cholecystokinin type B receptorHomo sapiens (human)0.1205
Gastrin/cholecystokinin type B receptorMus musculus (house mouse)0.0093

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Patchett, AA1

Other Studies

1 other study(ies) available for l 158809 and 2-(2-(5-bromo-1h-indol-3-yl)ethyl)-3-(1-methylethoxyphenyl)-4-(3h)-quinazolinone

ArticleYear
Excursions in drug discovery.
    Journal of medicinal chemistry, 1993, Jul-23, Volume: 36, Issue:15

    Topics: Awards and Prizes; Drug Design; Humans; Research; Technology, Pharmaceutical

1993